C07D 473 - Heterocyclic compounds containing purine ring systems

Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
12/2011
12/06/2011	US8071565 Purine derivatives as a2a agonists
12/06/2011	CA2600570C Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
12/01/2011	WO2011148956A1 Fused imidazole derivative
12/01/2011	WO2011147066A1 Arylamino purine derivatives, preparation method and pharmaceutical use thereof
12/01/2011	US20110294802 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2011	CA2800521A1 Fused imidazole derivative
11/2011
11/30/2011	EP2390257A1 2'-fluoronucleosides
11/30/2011	CN102264739A 新的中间体和应用所述中间体制备恩替卡韦的方法 Applying the new intermediates and intermediates for the preparation method of entecavir
11/30/2011	CN102260263A 一类二苯胺基嘌呤衍生物及制备方法和医药用途 A class dianilino purine derivatives and preparation method and medicinal uses
11/30/2011	CN102260262A 恩替卡韦的纯化方法及片剂 Entecavir purification methods and Tablets
11/30/2011	CN102260261A 恩替卡韦的纯化方法 Entecavir purification method
11/30/2011	CN102260260A 8-苯基黄嘌呤类化合物、其制备方法、包含该化合物的药物组合物及其用途 8-phenyl-xanthine compounds, methods for their preparation, pharmaceutical compositions comprising the compounds and their use
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/30/2011	CN101589044B 嘌呤核苷化合物结晶的制造方法 Method for producing a purine nucleoside compound crystallized
11/30/2011	CA2730622A1 Process for the synthesis of carbonucleoside and intermediates for use therein
11/30/2011	CA2705953A1 Carbanucleoside synthesis and novel intermediate compounds useful therein
11/29/2011	US8067426 6-amino-purin-8-one compounds
11/29/2011	US8067413 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
11/29/2011	US8067411 Compounds
11/24/2011	WO2011100698A3 Methods of treating viral infection
11/24/2011	US20110288296 Production and use of zinc amides
11/24/2011	US20110288106 Adenine receptor ligands
11/24/2011	US20110288053 Antiviral phosphonate analogs
11/24/2011	US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011	CA2799579A1 Chemical compounds, compositions and methods for kinase modulation
11/23/2011	CN102256977A Purine compounds
11/23/2011	CN102256976A Salt forms of organic compound
11/23/2011	CN102250126A Dipurine derivative and synthesis thereof
11/23/2011	CN102250094A 2-alkylthio-9-alcoxyalkyl adenine compound and synthesis thereof
11/23/2011	CN102250093A Process for recovering theophylline sodium salt from theophylline sodium salt mother liquid
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/22/2011	US8063081 Aryl carbonyl derivatives as therapeutic agents
11/22/2011	US8063051 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
11/22/2011	CA2480452C Thioxanthine derivatives as myeloperoxidase inhibitors
11/17/2011	US20110282031 A1 adenosine receptor diagnostic probes
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/16/2011	EP2027086B1 N-benzoyl-pyrrolidin-3-ylamines as histamine-3 antagonists
11/16/2011	CN102245607A Morpholinopurine derivative
11/16/2011	CN102245606A Novel compounds
11/16/2011	CN102245580A Novel substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/15/2011	US8058430 Biologically active aphrocallistin compounds
11/10/2011	WO2011063268A3 Process for preparing cycloalkylxanthines and intermediates thereof
11/10/2011	US20110275652 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents
11/10/2011	US20110275590 Conjugates for cancer therapy and diagnosis
11/09/2011	CN102234281A Pyrimidine-fused cyclic derivative
11/09/2011	CN102234280A D, L-guanosine analogs, preparation methods thereof and applications thereof
11/09/2011	CN101693713B New crystal system of entecavir, preparation process and medicament application thereof
11/09/2011	CN101560210B Method for synthesizing diprophylline
11/08/2011	US8053217 Method for producing eritadenine in liquid phase fermentation
11/03/2011	US20110269780 Aza-benzimidazolone chymase inhibitors
11/03/2011	US20110269778 Novel diphenyl purine derivatives useful as modulators of nicotinic acetylcholine receptors
11/03/2011	US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011	US20110269178 Fluorescent cdk inhibitors for treatment of cancer
11/02/2011	EP2382217A2 Novel intermediate and process for preparing entecavir using same
11/02/2011	EP2382216A1 Salt forms of organic compound
11/02/2011	CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/02/2011	CN102229608A Improved method for preparing entecavir
11/02/2011	CN101723945B Method for preparing antiviral medicinal entecavir intermediate
11/01/2011	CA2488834C Purine derivatives and their use as antiproliferative agents
10/2011
10/27/2011	WO2011059207A3 Arylpiperazine-containing purine derivatives and uses thereof
10/27/2011	US20110262661 Optical performance humidity dependency improving agent for cellulose acylate film
10/26/2011	EP2379749A1 Unsymmetrical cyanine dyes for high resolution nucleic acid melting analysis
10/26/2011	EP2379555A1 Purine compounds
10/26/2011	EP2139894B1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
10/26/2011	CN102227427A Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/26/2011	CN102225938A Novel synthesis process of entecavir monohydrate
10/25/2011	US8044061 8-alkynylxanthines and derivatives
10/25/2011	US8044056 Adenine compound
10/25/2011	CA2581225C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/20/2011	WO2011130557A2 Phosphonates with reduced toxicity for treatment of viral infections
10/20/2011	US20110257127 A2b adenosine receptor antagonists
10/19/2011	EP2377865A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/13/2011	US20110251387 Novel intermediate and process for preparing entecavir using same
10/13/2011	US20110251218 Novel compounds
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251172 Purine derivatives for treatment of alzheimer's disease
10/13/2011	CA2795514A1 Novel hypoglycemic compounds
10/12/2011	EP2373672A1 Novel flavour enhancer compounds
10/12/2011	EP2373163A1 Heterocyclic compounds and methods of use
10/12/2011	CN102216302A Akt and p70 s6 kinase inhibitors
10/12/2011	CN102212065A Isonucleoside compound or ortho-phosphite derivative thereof and preparation method and application thereof
10/11/2011	US8034820 Pharmaceutical composition
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2473736C Process for producing dioxolane nucleoside analogues
10/06/2011	WO2011123751A2 Heterocyclic compounds and their uses
10/06/2011	WO2011123482A1 Purine compounds used as cb2 agonists
10/06/2011	WO2011046303A3 Novel method for preparing entecavir and intermediate used therein
10/06/2011	US20110245458 Peptide nucleic acid monomers and oligomers
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245255 Purine compounds
10/06/2011	US20110245156 Novel antiviral compounds, compositions, and methods of use
10/06/2011	US20110244027 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods of Treating Viral Infections
10/06/2011	CA2795006A1 Purine compounds used as cb2 agonists
10/06/2011	CA2793897A1 Heterocyclic compounds and their uses
10/05/2011	EP2370440A1 Novel compounds
10/05/2011	CN101056879B Purine derivatives as A3 and A1 adenosine receptor agonists
10/04/2011	US8030495 Cyclopropyl pyrrolidine orexin receptor antagonists

1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 120